Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
A
|
Atrem SA
WSE:ATR
|
PL |
|
F
|
Flair Writing Industries Ltd
NSE:FLAIR
|
IN |
|
LifeTech Scientific Corp
HKEX:1302
|
CN |
|
T
|
Tamai Steamship Co Ltd
TSE:9127
|
JP |
|
TV Today Network Ltd
NSE:TVTODAY
|
IN |
|
M
|
Million Stars Holdings Ltd
HKEX:8093
|
HK |
|
I
|
I&I Group PCL
SET:IIG
|
TH |
|
GetNinjas SA
BOVESPA:NINJ3
|
BR |
|
S
|
Shenzhen Success Electronics Co Ltd
SZSE:002289
|
CN |
|
FreeBit Co Ltd
TSE:3843
|
JP |
|
Ning Xia Yin Xing Energy Co Ltd
SZSE:000862
|
CN |
|
S
|
Spotify Technology SA
SWB:639
|
LU |
|
Forian Inc
NASDAQ:FORA
|
US |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
BOVESPA:SBSP3
|
BR |
|
A
|
American CuMo Mining Corp
XTSX:MLY
|
CA |
|
Evolution Mining Ltd
ASX:EVN
|
AU |
|
B
|
BSEL Infrastructure Realty Ltd
BSE:532123
|
IN |
|
Z
|
Zhibao Technology Inc
NASDAQ:ZBAO
|
CN |
|
Beazer Homes USA Inc
NYSE:BZH
|
US |
|
Xlife Sciences AG
SIX:XLS
|
CH |
|
L
|
Limestone Boat Company Ltd
XTSX:BOAT
|
CA |
|
J
|
Jianzhong Construction Development Ltd
HKEX:589
|
CN |
|
Equity Residential
NYSE:EQR
|
US |
Multiples-Based Value
The Multiples-Based Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.54 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
17.4B CNY | 6.8 | 15.2 | 53.1 | 53.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |